Nithianandan Selliah
Global Head, Flow Cytometry
20 years in the industry and academia developing expertise in biomarker discovery, immunology, and regulatory affairs.
Scientific insight and customization for optimum solutions
At Cerba Research, we know that scientific expertise and insight are key to success.
With 25 years of extensive expertise in providing Flow Cytometry testing for clinical trials ranging from pre-clinical to phase III, we have a strong track record of designing, developing and validating custom-made flow cytometry panels.
We can use Flow Cytometry to monitor immunophenotyping, immune cell activation, drug receptor occupancy, CAR-T cell functionality across blood samples, bone marrow aspirates (BMA), and cryopreserved PBMCs.
The solutions for every challenges
Our comprehensive Flow Cytometry services offer precision, efficiency, and customization to support your study needs with:
- Early engagement and consultation ensures customer and study requirements are fully met..
- A quality framework specifically designed for Flow Cytometry, ensuring robust, reliable results.
- The proper resource allocation aligned with trial size, maximizing efficiency and scalability.
- The development and validation of assays within agreed timelines deliver timely support for your research.
- Efficient sample management, with a prompt scientific review of patient data to maintain data integrity and accuracy.
Designing, developing, validating, and implementing assays through a global network
Flow Cytometry laboratory hubs
Assess more than 40 parameters with the Cytek Aurora
With our spectral Flow Cytometry capabilities, we simultaneously characterize cellular populations from the same tube with a complete set of data from the sample, all while reducing the time of sample acquisition.
Cerba Research is proud to answer your exploratory needs for clinical trials and retrospective analysis with our state of art instruments and high quality data output.
Quality Framework
Cerba Research has developed a robust quality framework specifically for Flow Cytometry assays with the backing of a CAP-accredited laboratory network. With rigorous oversight and rapid quality checks, any technical or sample issues are detected and resolved immediately, ensuring the reliability of your results.
Client-specific
Validation
Harmonized
Flow Cytometry Services
Design, Development & Panel Validation
We provide Flow Cytometry testing for a variety of biomarkers, and build panels for your study.
Flow Cytometry Custom Assay Development
Our scientific team can develop and validate Flow Cytometry panels specifically tailored to your research.
CAR+T Drug Development: The Critical Role of Flow Cytometry
In our CAR+T Drug Development ebook, Ans De Beuckelaer, Regional Head Flow Cytometry EU, and Rowan Claeys, Clinical Biologist at Cerba Research, dive deeper into key elements of Flow Cytometry:
- The importance of Flow Cytometry in CAR+T clinical research and its uses
- Key aspects in developing a CAR+ T trial
- The added value of Flow Cytometry in multiple myeloma, Minimal Residual Disease (MRD) assessments, and multiple myeloma phenotype
- CAR+T-cell Therapy: patient treatment, targeted antigens and solutions for MRD assessments and multiple myeloma phenotype assessment.
Innovative Compound Development: Cerba Research’s Strategic Approach to Flow Cytometry
Do you wonder how Flow Cytometry can supports precise immunophenotyping, immune cell monitoring, and CAR-T analysis?
Discover our tailored quality framework, strategic resource allocation, and efficient assay management—all designed to enhance your clinical research. Watch anytime for insights on maximizing Flow Cytometry’s impact.
Contact us today to find out how we can help you plan and deliver for your next study to achieve optimum results.